Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Collplant Biotechnologies Ltd
(NQ:
CLGN
)
14.90
USD
UNCHANGED
Streaming Delayed Price
Updated: 4:52 PM EST, Jan 25, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
14.90
Bid (Size)
14.90 (1)
Ask (Size)
16.45 (1)
Prev. Close
14.90
Today's Range
14.90 - 14.90
52wk Range
6.000 - 16.32
Shares Outstanding
3,423,213
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications
December 10, 2020
rhCollagen is to be included in cell culture kits sold to scientists worldwide working in the stem cell, immunology, cancer, regenerative medicine, and cellular therapy research fields
From
PR Newswire
CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update
December 01, 2020
- Expanded collaboration agreement with United Therapeutics which exercised its option for 3D bioprinted kidney transplants and $3 million payment to CollPlant
From
PR Newswire
Performance
YTD
+37.71%
+37.71%
1 Month
+41.10%
+41.10%
3 Month
+108.68%
+108.68%
6 Month
+66.57%
+66.57%
1 Year
+45.06%
+45.06%
More News
Read More
CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients
November 10, 2020
From
PR Newswire
CollPlant Receives Substantial First Order for its Vergenix™ Flowable Gel Product in Ukraine
October 26, 2020
From
PR Newswire
CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant
September 21, 2020
From
PR Newswire
CollPlant Biotechnologies Presents on the Use of Novel, Plant-Derived, Recombinant Human Collagen for Anti-Aging Therapies at the Science of Aging Virtual Symposium 2020
September 16, 2020
From
PR Newswire
CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)
September 14, 2020
From
PR Newswire
CollPlant Biotechnologies to Present at Science of Aging Virtual Symposium 2020 During Healthy Aging Month
August 31, 2020
From
PR Newswire
CollPlant Biotechnologies Reports Second Quarter (Q2) 2020 Financial Results
August 28, 2020
From
PR Newswire
CollPlant Biotechnologies Reports First Quarter (Q1) 2020 Financial Results
May 27, 2020
From
PR Newswire
Collplant to Host Webinar Highlighting its Plant-based, Human Recombinant Collagen (rhCollagen) Platform for the Future of Aesthetic and Regenerative Medicine
May 05, 2020
From
PR Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.